Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Neutropenia 1Neoplasms 1Hematologic Neoplasms 1Febrile Neutropenia 1

Interventions

Cyclophosphamide 7fludarabine phosphate 5Whole-Body Irradiation 5Mycophenolic Acid 4Busulfan 4fludarabine 3Tacrolimus 3Rituximab 3Peripheral Blood Stem Cell Transplantation 3Melphalan 3Cyclosporine 3Biopsy 3venetoclax 2apixaban 2Tretinoin 2Specimen Handling 2Methotrexate 2Lenalidomide 2Etoposide 2CT-P10 2Azacitidine 2Antilymphocyte Serum 2thymoglobulin 1merphos 1ivosidenib 1ibrutinib 1edoxaban 1decitabine and cedazuridine drug combination 1acalabrutinib 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Amikacin × Classical hematology × 30 days × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡